Skip to main content
Recall Canary
Abiomed Automated Impella Controller
← Back to all recalls
MEDICAL DEVICE RECALLCRITICAL

Abiomed Automated Impella Controller

Abiomed is recalling 30+ models of Impella Controllers due to a software error that may affect left ventricular support devices.

What to do

Healthcare providers should review the manufacturer's urgent medical device correction notice for specific software update instructions and operational guidance. Contact Abiomed for further technical support.

Posted
Updated
Recall No.
Z-2360-2026
Agency
Firm
Abiomed, Inc.
Recall ID
98853
Status
ONGOING

Why it was recalled

Abiomed is recalling 30+ variants of the Automated Impella Controller and Impella Optical Controller used with left ventricular support devices due to a potential software error. The full list of affected product codes is available on the FDA recall page.

Is mine affected?

Check the model, lot, or serial number on the device or its packaging. Yours is affected if it matches one below.

ProductUPCRecall #
Automated Impella Controller (AIC), for use with left heart support blood pump. Labeled as the following with corresponding Product Codes: 1. Impella Controller, Packaged, AU; Product Code: 0042-0000-AU. 2. Impella Controller, Packaged, CA; Product Code: 0042-0000-CA. 3. Impella Controller, Packaged, EU; Product Code: 0042-0000-EU. 4. Impella Controller, Packaged, IN; Product Code: 0042-0000-IN. 5. Impella Controller, Packaged, JP; Product Code: 0042-0000-JP. 6. Impella C00813502010886, 00813502011272, 00813502011289, 00813502010930, 00813502010961, 00813502011425, 00813502010978, 00813502010985, 00813502012958, 00813502012217, 00813502011814, 00813502012972, 00813502012484, 00813502011401Z-2360-2026
Automated Impella Controller (AIC), for use with left heart support blood pump. Labeled as the following with corresponding Product Codes

Where it was sold

Distributed nationwide.

Other recent recalls from Abiomed, Inc.

← Back to all recalls

Editorial summary by Recall Canary · last updated 2026-06-13 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification